Phase I Trial of the Safety, Toxicity, and Acceptability of the Microbicide UC-781 When Topically Applied by HIV-Uninfected Women and Men in Botswana

Trial Profile

Phase I Trial of the Safety, Toxicity, and Acceptability of the Microbicide UC-781 When Topically Applied by HIV-Uninfected Women and Men in Botswana

Withdrawn prior to enrolment
Phase of Trial: Phase I

Latest Information Update: 15 Aug 2012

At a glance

  • Drugs UC 781 (Primary)
  • Indications HIV infections
  • Focus Adverse reactions
  • Most Recent Events

    • 15 Aug 2012 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov record.
    • 05 Jun 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top